| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 12,380,000 | 13,910,000 | 12,467,000 | 12,372,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 12,380,000 | 13,910,000 | 12,467,000 | 12,372,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,666,000 | 1,647,000 | (640,000) | 1,023,000 | | Non Recurring |
-
| 1,858,000 |
-
|
-
| | Others | 20,334,000 | 28,649,000 | 14,898,000 | 5,682,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (16,620,000) | (18,244,000) | (1,791,000) | 5,667,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1,714,000 | (1,714,000) |
-
| | Earnings Before Interest And Taxes | (16,620,000) | (16,531,000) | (3,480,000) | 5,664,000 | | Interest Expense | 7,188,000 | 8,274,000 | 8,408,000 | 8,407,000 | | Income Before Tax | (23,808,000) | (24,805,000) | (11,888,000) | (2,743,000) | | Income Tax Expense | (623,000) | 142,000 | 17,011,000 | (476,000) | | Minority Interest |
-
| (1,000) | 25,000 | (3,000) | | | | Net Income From Continuing Ops | (23,185,000) | (24,947,000) | (28,899,000) | (2,267,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
| (280,000) | (95,000) | (33,000) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (23,185,000) | (25,227,000) | (28,994,000) | (2,300,000) | | Preferred Stock And Other Adjustments | (12,000) | (25,000) | (419,000) | (303,000) | | | Net Income Applicable To Common Shares | ($23,197,000) | ($25,252,000) | ($29,413,000) | ($2,603,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
